BIIB vs UNH · P/E 21, rev $9.89B vs P/E 30, rev $112.03B
Biogen Inc (BIIB) versus UnitedHealth Group Incorporated (UNH) — a side-by-side from cached financials, not a winner call.
Biogen Inc (BIIB) is a drug manufacturers - general company listed on NASDAQ. It is led by Christopher A. Viehbacher.
UnitedHealth Group Incorporated (UNH) is a healthcare plans company listed on NYSE. It is led by Stephen J. Hemsley.
Latest reported BIIB revenue for 2025-12-31 was $9.89B. Net income was $1.29B. Revenue was up 2.2% from 2024-12-31 to 2025-12-31. BIIB currently screens at market cap $29.33B and trailing P/E 21.4.
Latest reported UNH revenue for 2026-06-30 was $112.03B. Net income was $5.48B. Revenue was up 0.3% from 2026-03-31 to 2026-06-30. UNH currently screens at market cap $362.83B and trailing P/E 30.1.
BIIB currently screens at market cap $29.33B and trailing P/E 21.4. UNH currently screens at market cap $362.83B and trailing P/E 30.1.
Not investment advice. Open the BIIB and UNH stock pages for the full models.
Not investment advice.